InDex Pharmaceuticals Holding AB Share Price Nasdaq Stockholm
Equities
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- SEK | - |
04-26 | InDex Pharmaceuticals Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-05 | Index Pharmaceuticals Holding AB Announces Board Resignations | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 210M 2.29B 16.79B |
---|---|---|---|---|---|
Net income 2024 * | -259M -2.83B -20.72B | Net income 2025 * | -221M -2.41B -17.68B | EV / Sales 2024 * | - |
Net Debt 2024 * | 86.32M 942M 6.9B | Net Debt 2025 * | 306M 3.34B 24.46B | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.8
x | P/E ratio 2025 * |
-0.96
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 62.47% |
Managers | Title | Age | Since |
---|---|---|---|
Jenny Sundqvist
CEO | Chief Executive Officer | 53 | 31/12/22 |
Johan Gileus
DFI | Director of Finance/CFO | 59 | 30/04/17 |
Charlotte Admyre
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Uli Alf Hacksell
BRD | Director/Board Member | 74 | 31/12/15 |
Director/Board Member | 68 | 31/12/10 | |
Chairman | 72 | 31/12/10 |
1st Jan change | Capi. | |
---|---|---|
+30.88% | 699B | |
+25.07% | 571B | |
-4.61% | 364B | |
+18.18% | 326B | |
+3.07% | 286B | |
+14.68% | 236B | |
+4.71% | 198B | |
-12.43% | 194B | |
-4.52% | 154B |